23 Papers
4 Citations
Eby Sim is an academic researcher from Ministry of Health (New South Wales). The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 3 publications. Previous affiliations of Eby Sim include Westmead Hospital.
Chat about Author
Papers
Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
Rebecca J. Rockett,Rebecca J. Rockett,Alicia Arnott,Alicia Arnott,Alicia Arnott,Connie Lam,Connie Lam,Rosemarie Sadsad,Rosemarie Sadsad,Verlaine J. Timms,Verlaine J. Timms,Karen-Ann Gray,Karen-Ann Gray,John-Sebastian Eden,Sheryl L. Chang,Mailie Gall,Jenny Draper,Eby Sim,Eby Sim,Nathan L. Bachmann,Nathan L. Bachmann,Ian Carter,Kerri Basile,Roy Byun,Matthew V. N. O'Sullivan,Matthew V. N. O'Sullivan,Matthew V. N. O'Sullivan,Sharon C.-A. Chen,Sharon C.-A. Chen,Sharon C.-A. Chen,Susan Maddocks,Tania C. Sorrell,Tania C. Sorrell,Dominic E. Dwyer,Dominic E. Dwyer,Dominic E. Dwyer,Edward C. Holmes,Jen Kok,Jen Kok,Jen Kok,Mikhail Prokopenko,Vitali Sintchenko +41 more
TL;DR: The prospective sequencing of SARS-CoV-2 clarified the probable source of infection in cases where epidemiological links could not be determined, significantly decreased the proportion of COVID-19 cases with contentious links, documented genomically similar cases associated with concurrent transmission in several institutions and identified previously unsuspected links.
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
Rebecca Rockett,Jenny Draper,Mailie Gall,Eby Sim,Alicia Arnott,Jessica E. Agius,Jessica Johnson-Mackinnon,Winkie Fong,Elena Martinez,Alexander P. Drew,Clement Lee,Christine Ngo,Marc Ramsperger,Andrew N. Ginn,Qinning Wang,Michael Fennell,Danny Ko,Linda Hueston,Lukas Kairaitis,Edward C. Holmes,Matthew V. N. O'Sullivan,Sharon C.-A. Chen,Jen Kok,Dominic E. Dwyer,Vitali Sintchenko +24 more
TL;DR: In this paper , the authors describe co-infection with the SARS-CoV-2 variants of concern Omicron and Delta in two epidemiologically unrelated adult patients with chronic kidney disease requiring maintenance haemodialysis.
The evolution and international spread of extensively drug resistant Shigella sonnei
Lewis C E Mason,David R. Greig,Lauren A. Cowley,Sally R. Partridge,Elena Martinez,Grace A. Blackwell,Charlotte E. Chong,P. Malaka De Silva,Rebecca J. Bengtsson,Jenny Draper,Andrew N. Ginn,Indy Sandaradura,Eby Sim,Jonathan R. Iredell,Vitali Sintchenko,Danielle J. Ingle,Benjamin P Howden,Sophie D. Lefevre,François-Xavier Weill,Pieter-Jan Ceyssens,Claire Jenkins,Kate S. Baker +21 more
TL;DR: In this paper , the authors identify the genetic basis, evolutionary history, and international dissemination of the outbreak strain of Shigella sonnei in the United Kingdom, Australia, Belgium, France, and the United States of America.
Revealing COVID-19 Transmission by SARS-CoV-2 Genome Sequencing and Agent Based Modelling
Rebecca J. Rockett,Alicia Arnott,Connie Lam,Rosemarie Sadsad,Verlaine J. Timms,Karen-Ann Gray,John-Sebastian Eden,Sheryl L. Chang,Mailie Gall,Jenny Draper,Eby Sim,Nathan L. Bachmann,Ian Carter,Kerri Basile,Roy Byun,Matthew V O Sullivan,Sharon C.-A. Chen,Susan Maddocks,Tania C. Sorrell,Dominic E. Dwyer,Edward C. Holmes,Jen Kok,Mikhail Prokopenko,Vitali Sintchenko +23 more
TL;DR: Convergent assessment indicates that genome sequencing provides key information to inform public health action and has improved the understanding of the COVID-19 evolution from outbreak to epidemic.
Advancing pathogen genomics in resource-limited settings
Paul Michael Pronyk,Ruklanthi de Alwis,Rebecca Rockett,Kerri Basile,Yann Felix Boucher,Vincent Pang,October Sessions,Marya Getchell,Tanya Golubchik,Connie Lam,Raymond Lin,Tze-Minn Mak,Ben Marais,Rick Twee-Hee Ong,Hannah Eleanor Clapham,Linfa Wang,Yorin Cahyorini,Francisco Gerardo M. Polotan,Yuni Rukminiati,Eby Sim,Carl Suster,Gavin J.D. Smith,Vitali Sintchenko +22 more
TL;DR: A public health approach to genomics is adopted and the value proposition for genomics is assessed to inform public health and clinical decision-making, alongside its contribution toward research and development of novel diagnostics, therapeutics, and vaccines.
22